Vapiprost

Drug Profile

Vapiprost

Alternative Names: GR 32191; GR 32191B; SN 309

Latest Information Update: 17 Jan 2008

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator GlaxoSmithKline
  • Developer GlaxoSmithKline; GlaxoSmithKline KK
  • Class Antiplatelets
  • Mechanism of Action Thromboxane receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Asthma; Coronary artery restenosis; Deep vein thrombosis; Ischaemic heart disorders

Most Recent Events

  • 01 Sep 1999 No-Development-Reported for Coronary artery restenosis in Japan (Unknown route)
  • 01 Sep 1999 No-Development-Reported for Deep vein thrombosis in Japan (Unknown route)
  • 21 Aug 1996 A study has been added to the Ischaemic Heart Disease and Thromboses therapeutic trials sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top